ddctp

ddCTP, one of the 2',3'-dideoxyribonucleoside 5'-triphosphates (ddNTPs), functions as a chain-elongating inhibitor of DNA polymerase for DNA sequencing.

5-Propargylamino-ddCTP is a nucleoside molecule utilized in the synthesis of cyanine dye-nucleotide conjugate, which finds application in nucleic acid labeling and sequence analysis.

5-Propargylamino-ddCTP 3TEA is a derivative and modified nucleotide of ddCTP, used in gene sequencing. ddCTP is one of the chain terminators used in Sanger sequencing.

ddCTP trisodium is a nucleoside analogue that targets the human immunodeficiency virus (HIV) reverse transcriptase and is used in AIDS research. ddCTP trisodium is a class of dideoxyribonucleotides (ddNTPs) and a DNA polymerase chain extension inhibitor that can be used in DNA sequencing research. ddCTP trisodium is a nucleoside analogue that targets the human immunodeficiency virus (HIV) reverse transcriptase and is used in AIDS research.

ddCTP trilithium is one of the 2',3'-dideoxyribonucleoside 5'-triphosphates (ddNTPs) that acts as a chain-elongating inhibitor of DNA polymerase for DNA sequencing. It is a nucleoside analog targeting the reverse transcriptase of human immunodeficiency virus (HIV) and can be used for AIDS research [1] [2].

5-Propargylamino-ddCTP (trisodium) solution (25mM) is a nucleoside molecule utilized in synthesizing anthocyanin dye-nucleotide conjugates, which are used for nucleic acid labeling or sequence analysis.

3′-Azido-ddCTP sodium is a labeled and modified deoxynucleoside triphosphate (dNTP) that acts as chain-elongating inhibitor of DNA polymerase for DNA sequencing.

3'-NH2-ddCTP sodium is a labeled and modified deoxynucleoside triphosphate (dNTP) that acts as chain-elongating inhibitor of DNA polymerase for DNA sequencing.

ddCTPαS tetrasodium is a dideoxynucleotide that is utilized in DNA sequencing.

3′-Azido-2′,3′-dideoxy-CTP (AZddCTP) is a cytidine analogue containing a 3-azido group. It functions as a chain terminator when incorporated into nascent DNA strands by HIV reverse transcriptase, effectively inhibiting DNA synthesis due to the absence of a 3'-hydroxyl group, thereby blocking viral replication. The IC50 for WTHIV is 15.6 μM, and for AZTRHIV, it is 160.8 μM. This compound exhibits antiviral activity.